3-148991655-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_004130.4(GYG1):c.7+8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000653 in 1,530,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004130.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYG1 | NM_004130.4 | c.7+8C>T | splice_region_variant, intron_variant | ENST00000345003.9 | NP_004121.2 | |||
GYG1 | NM_001184720.2 | c.7+8C>T | splice_region_variant, intron_variant | NP_001171649.1 | ||||
GYG1 | NM_001184721.2 | c.7+8C>T | splice_region_variant, intron_variant | NP_001171650.1 | ||||
GYG1 | XM_017006275.2 | c.-35+8C>T | splice_region_variant, intron_variant | XP_016861764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYG1 | ENST00000345003.9 | c.7+8C>T | splice_region_variant, intron_variant | 1 | NM_004130.4 | ENSP00000340736 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151956Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000771 AC: 1AN: 129620Hom.: 0 AF XY: 0.0000140 AC XY: 1AN XY: 71584
GnomAD4 exome AF: 0.00000580 AC: 8AN: 1379022Hom.: 0 Cov.: 30 AF XY: 0.00000587 AC XY: 4AN XY: 681196
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151956Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74232
ClinVar
Submissions by phenotype
Glycogen storage disease XV;C4015452:Polyglucosan body myopathy type 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 14, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at